ClinicalTrials.gov record
Recruiting Phase 3 Interventional

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

ClinicalTrials.gov ID: NCT07228832

Public ClinicalTrials.gov record NCT07228832. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:15 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Active-Controlled, Double-blind, Multicenter, Phase 3 Clinical Study of Ivonescimab in Combination With FOLFOX Versus Bevacizumab in Combination With FOLFOX for the First-line Treatment of Metastatic Colorectal Cancer

Study identification

NCT ID
NCT07228832
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Summit Therapeutics
Industry
Enrollment
600 participants

Conditions and interventions

Interventions

  • Drug: Bevacizumab Injection Drug
  • Drug: Ivonescimab Injection Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 17, 2025
Primary completion
May 30, 2028
Completion
Nov 29, 2029
Last update posted
May 4, 2026

2025 – 2029

United States locations

U.S. sites
58
U.S. states
21
U.S. cities
51
Facility City State ZIP Site status
Clinical Study Site Goodyear Arizona 85338 Recruiting
Clinical Study Site Beverly Hills California 90211 Recruiting
Clinical Study Site Beverly Hills California 90212 Recruiting
Clinical Study Site Cerritos California 90703 Recruiting
Clinical Study Site Corona California 92882 Recruiting
Clinical Study Site Duarte California 91010 Recruiting
Clinical Study Site Fountain Valley California 92708 Recruiting
Clinical Study Site Huntington Beach California 92648 Recruiting
Clinical Study Site Irvine California 92612 Recruiting
Clinical Study Site Irvine California 92618 Recruiting
Clinical Study Site Los Angeles California 90027 Recruiting
Clinical Study Site Los Angeles California 90067 Recruiting
Clinical Study Site Los Angeles California 90404 Recruiting
Clinical Study Site Murrieta California 92562 Recruiting
Clinical Study Site Orange California 92868 Recruiting
Clinical Study Site Pasadena California 91030 Recruiting
Clinical Study Site Torrance California 90503 Recruiting
Clinical Study Site Upland California 91786 Recruiting
Clinical Study Site West Hollywood California 90048 Recruiting
Clinical Study Site Hartford Connecticut 06106 Recruiting
Clinical Study Site New Haven Connecticut 06520-8028 Recruiting
Clinical Study Site Norwich Connecticut 06360 Recruiting
Clinical Study Site Hialeah Florida 33013 Recruiting
Clinical Study Site Miami Florida 33176 Recruiting
Clinical Study Site Orlando Florida 32806 Recruiting
Clinical Study Site Plantation Florida 33322 Recruiting
Clinical Study Site Port Saint Lucie Florida 34952 Recruiting
Clinical Study Site Tamarac Florida 33321 Recruiting
Clinical Study Site Newnan Georgia 30265 Recruiting
Clinical Study Site Chicago Illinois 60611 Recruiting
Clinical Study Site Elmhurst Illinois 60540 Recruiting
Clinical Study Site O'Fallon Illinois 62269 Recruiting
Clinical Study Site Fort Wayne Indiana 46804 Recruiting
Clinical Study Site Indianapolis Indiana 46202 Recruiting
Clinical Study Site Edgewood Kentucky 41017 Recruiting
Clinical Study Site Saint Louis Park Minnesota 55426 Recruiting
Clinical Study Site Billings Montana 59102 Recruiting
Clinical Study Site Lincoln Nebraska 68506 Recruiting
Clinical Study Site New Brunswick New Jersey 08901 Recruiting
Clinical Study Site Mineola New York 11501 Recruiting
Clinical Study Site New York New York 10016 Recruiting
Clinical Study Site The Bronx New York 10461 Recruiting
Clinical Study Site Akron Ohio 44032 Recruiting
Clinical Study Site Canton Ohio 44703 Recruiting
Clinical Study Site Cincinnati Ohio 45219 Recruiting
Clinical Study Site Cincinnati Ohio 45220 Recruiting
Clinical Study Site Cleveland Ohio 44111 Recruiting
Clinical Study Site Cleveland Ohio 44195 Recruiting
Clinical Study Site Mayfield Heights Ohio 44124 Recruiting
Clinical Study Site Philadelphia Pennsylvania 19111 Recruiting
Clinical Study Site Philadelphia Pennsylvania 19140 Recruiting
Clinical Study Site Hermitage Tennessee 37129 Recruiting
Clinical Study Site Fort Worth Texas 76104 Recruiting
Clinical Study Site Salt Lake City Utah 84106 Recruiting
Clinical Study Site Charlottesville Virginia 22908 Recruiting
Clinical Study Site Spokane Washington 99208 Recruiting
Clinical Study Site Tacoma Washington 98405 Recruiting
Clinical Study Site Charleston West Virginia 25304 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 18 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07228832, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 4, 2026 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07228832 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →